Contact

All Stories

  1. Human sex chromosome aneuploidies: The hypothalamic–pituitary–gonadal axis

    Article • American Journal of Medical Genetics Part C Seminars in Medical Genetics, March 2020, Wiley

    Dr Alan David Rogol

  2. Testing for growth hormone deficiency in children

    Article • Growth Hormone & IGF Research, February 2020, Elsevier

    Dr Alan David Rogol

  3. Bio-Banding in Youth Sports: Background, Concept, and Application

    Article • Sports Medicine, August 2019, Springer Science + Business Media

    Dr Alan David Rogol

  4. Low Risk of Adrenal Insufficiency After Use of Low- to Moderate-Potency Topical Corticosteroids for Children With Atopic Dermatitis

    Article • Clinical Pediatrics, January 2019, SAGE Publications

    Dr Alan David Rogol

  5. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium

    Article • Hormone Research in Paediatrics, January 2019, Karger Publishers

    Dr Alan David Rogol

  6. Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach

    Article • Hormone Research in Paediatrics, January 2019, Karger Publishers

    Dr Alan David Rogol

  7. Should survivors of childhood cancer or testicular cancer be screened for androgen deficiency?

    Article • Clinical Endocrinology, July 2018, Wiley

    Dr Alan David Rogol

  8. Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies

    Article • Canadian Urological Association Journal, March 2018, Canadian Urological Association Journal

    Dr Alan David Rogol

  9. Short children born small for gestational age outcomes in the era of growth hormone therapy

    Article • Growth Hormone & IGF Research, February 2018, Elsevier

    Dr Alan David Rogol

  10. The Interconnected Histories of Endocrinology and Eligibility in Women’s Sport

    Article • Hormone Research in Paediatrics, January 2018, Karger Publishers

    Dr Alan David Rogol

  11. Evaluation of Hypothalamic-Pituitary-Adrenal Axis Suppression following Cutaneous Use of Topical Corticosteroids in Children: A Meta-Analysis

    Article • Hormone Research in Paediatrics, January 2018, Karger Publishers

    Dr Alan David Rogol

  12. Genes, Gender, Hormones, and Doping in Sport: A Convoluted Tale

    Article • Frontiers in Endocrinology, October 2017, Frontiers

    Dr Alan David Rogol

  13. Cushing’s Disease in Children and Adolescents: Diagnosis and Management

    Article • January 2017, Elsevier

    Dr Alan David Rogol

  14. Treatment of growth hormone deficiency in children, adolescents and at the transitional age

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, December 2016, Elsevier

    Dr Alan David Rogol

  15. The Klinefelter syndrome: current management and research challenges

    Article • Andrology, May 2016, Wiley

    Dr Alan David Rogol

  16. Sperm retrieval in adolescent males with Klinefelter syndrome: medical and ethical issues

    Article • Translational Pediatrics, April 2016, AME Publishing Company

    Dr Alan David Rogol

  17. Endocrine Responses to Exercise in the Developing Child and Adolescent

    Article • January 2016, Karger Publishers

    Dr Alan David Rogol

  18. Natesto™, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men

    Article • Andrology, December 2015, Wiley

    Dr Alan David Rogol

  19. Testis Development and Fertility Potential in Boys with Klinefelter Syndrome

    Article • Endocrinology and Metabolism Clinics of North America, December 2015, Elsevier

    Dr Alan David Rogol

  20. Biological maturation of youth athletes: assessment and implications

    Article • British Journal of Sports Medicine, June 2015, BMJ

    Dr Alan David Rogol

  21. Can Anabolic Steroids or Human Growth Hormone Affect the Growth and Maturation of Adolescent Athletes?

    Article • Pediatric Exercise Science, November 2014, Human Kinetics

    Dr Alan David Rogol

  22. Hurdling Over Sex? Sport, Science, and Equity

    Article • Archives of Sexual Behavior, August 2014, Springer Science + Business Media

    Dr Alan David Rogol, Francisco J. Sánchez

  23. Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

    Article • Endocrine Reviews, June 2014, Endocrine Society

    Dr Alan David Rogol

  24. Etiologies and Early Diagnosis of Short Stature and Growth Failure in Children and Adolescents

    Article • The Journal of Pediatrics, May 2014, Elsevier

    Dr Alan David Rogol

  25. Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations

    Article • Clinical Endocrinology, February 2014, Wiley

    Dr Alan David Rogol

  26. A Multicenter, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Klinefelter Syndrome or Anorchia

    Article • Journal of Adolescent Health, January 2014, Elsevier

    Dr Alan David Rogol

  27. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, December 2013, Elsevier

    Dr Alan David Rogol

  28. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, December 2013, Elsevier

    Dr Alan David Rogol

  29. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, November 2013, Elsevier

    Dr Alan David Rogol

  30. Lactose Intolerance: Lack of Evidence for Short Stature or Vitamin D Deficiency in Prepubertal Children

    Article • PLoS ONE, October 2013, PLOS

    Dr Alan David Rogol

  31. Children with Asymptomatic Short Stature: What Is an Appropriate Evaluation?

    Article • The Journal of Pediatrics, October 2013, Elsevier

    Dr Alan David Rogol

  32. Traumatic brain injury: endocrine consequences in children and adults

    Article • Endocrine, September 2013, Springer Science + Business Media

    Dr Alan David Rogol

  33. Neuroendocrine alterations in the exercising human: Implications for energy homeostasis

    Article • Metabolism, July 2013, Elsevier

    Dr Alan David Rogol

  34. Role of Intensive Training in the Growth and Maturation of Artistic Gymnasts

    Article • Sports Medicine, June 2013, Springer Science + Business Media

    Dr Alan David Rogol

  35. Biological markers of tissue-specific effects of GH therapy

    Article • Nature Reviews Endocrinology, April 2013, Springer Science + Business Media

    Dr Alan David Rogol

  36. Testosterone exposure in childhood: discerning pathology from physiology

    Article • Expert Opinion on Drug Safety, March 2013, Informa Healthcare

    Dr Alan David Rogol

  37. Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: A preliminary study

    Article • Brain Injury, February 2013, Taylor & Francis

    Dr Alan David Rogol

  38. Recent updates on recombinant human growth hormone outcomes and adverse events

    Article • Current Opinion in Endocrinology Diabetes and Obesity, February 2013, Wolters Kluwer Health

    Dr Alan David Rogol

  39. Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels

    Article • Clinical Endocrinology, January 2013, Wiley

    Dr Alan David Rogol

  40. Prepubertal Children with Growth Hormone Deficiency Treated for Four Years with Growth Hormone Experience Dose-Dependent Increase in Height, but Not in the Rate of Puberty Initiation

    Article • Hormone Research in Paediatrics, January 2013, Karger Publishers

    Dr Alan David Rogol

  41. Biological assessment of abnormal genitalia

    Article • Journal of Pediatric Urology, December 2012, Elsevier

    Dr Alan David Rogol

  42. Pediatricians and Hypothalamic/Pituitary Tumors: What is it about Them in Children and Adolescents that Alert us to their Presence?

    Article • The Journal of Pediatrics, November 2012, Elsevier

    Dr Alan David Rogol

  43. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, October 2012, Elsevier

    Dr Alan David Rogol

  44. Diabetes Mellitus and Growth in Children and Adolescents

    Article • The Journal of Pediatrics, June 2012, Elsevier

    Dr Alan David Rogol

  45. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, May 2012, Elsevier

    Dr Alan David Rogol

  46. Secondary exposure to testosterone from patients receiving replacement therapy with transdermal testosterone gels

    Article • Current Medical Research and Opinion, January 2012, Informa Healthcare

    Dr Alan David Rogol

  47. Stroke in a child with Adams-Oliver syndrome and mixed diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2012, De Gruyter

    Dr Alan David Rogol

  48. How Does an Anabolic/Androgenic Steroid Get Banned from Sport Competition?

    Article • Endocrinology, December 2011, Endocrine Society

    Dr Alan David Rogol

  49. Optimizing Potential for Fertility: Fertility Considerations for the Pediatrician

    Article • Pediatric Clinics of North America, October 2011, Elsevier

    Dr Alan David Rogol

  50. Effects of short-course androgen therapy on the neurodevelopmental profile of infants and children with 49,XXXXY syndrome

    Article • Acta Paediatrica, April 2011, Wiley

    Dr Alan David Rogol

  51. 50 Years Ago in The Journal of Pediatrics

    Article • The Journal of Pediatrics, March 2011, Elsevier

    Dr Alan David Rogol

  52. Sports, Hormones, and Doping in Children and Adolescents

    Article • September 2010, Springer Science + Business Media

    Dr Alan David Rogol

  53. Traumatic Brain Injury in Children and Adolescents: Surveillance for Pituitary Dysfunction

    Article • Clinical Pediatrics, August 2010, SAGE Publications

    Dr Alan David Rogol

  54. Variable Degree of Growth Hormone (GH) and Insulin-Like Growth Factor (IGF) Sensitivity in Children with Idiopathic Short Stature Compared with GH-Deficient Patients: Evidence from an IGF-Based Dosing Study of Short Children

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2010, Endocrine Society

    Dr Alan David Rogol

  55. Ghrelin and growth hormone: Story in reverse

    Article • Proceedings of the National Academy of Sciences, April 2010, Proceedings of the National Academy of Sciences

    Dr Alan David Rogol

  56. Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2010, Endocrine Society

    Dr Alan David Rogol

  57. Clinical variability and novel neurodevelopmental findings in 49, XXXXY syndrome

    Article • American Journal of Medical Genetics Part A, January 2010, Wiley

    Dr Alan David Rogol

  58. Current Indications for Growth Hormone Therapy for Children and Adolescents

    Article • January 2010, Karger Publishers

    Dr Alan David Rogol

  59. Drugs of abuse and the adolescent athlete

    Article • Italian Journal of Pediatrics, January 2010, Springer Science + Business Media

    Dr Alan David Rogol

  60. Optimizing Potential for Fertility: Fertility Preservation Considerations for the Pediatric Endocrinologist

    Article • Endocrinology and Metabolism Clinics of North America, December 2009, Elsevier

    Dr Alan David Rogol

  61. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?

    Article • Growth Hormone & IGF Research, August 2009, Elsevier

    Dr Alan David Rogol

  62. Position Stand on Androgen and Human Growth Hormone Use

    Article • The Journal of Strength and Conditioning Research, August 2009, Wolters Kluwer Health

    Dr Alan David Rogol

  63. Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children

    Article • PEDIATRICS, March 2009, American Academy of Pediatrics (AAP)

    Dr Alan David Rogol

  64. Sex Steroids, Growth Hormone, Leptin and the Pubertal Growth Spurt

    Article • January 2009, Karger Publishers

    Dr Alan David Rogol

  65. Recombinant human insulin-like growth factor-I therapy for children with growth disorders

    Article • Advances in Therapy, December 2008, Springer Science + Business Media

    Dr Alan David Rogol

  66. APPARENT GROWTH HORMONE DEFICIENCY IN CHILDREN WITH CEREBRAL PALSY

    Article • Developmental Medicine & Child Neurology, November 2008, Wiley

    Dr Alan David Rogol

  67. Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2008, Endocrine Society

    Dr Alan David Rogol

  68. Reflections on Future Research in Adolescent Reproductive Health

    Article • Annals of the New York Academy of Sciences, June 2008, Wiley

    Dr Alan David Rogol

  69. Growth hormone deficiency in children

    Article • Pituitary, April 2008, Springer Science + Business Media

    Dr Alan David Rogol

  70. Idiopathic short stature: Definition, epidemiology, and diagnostic evaluation

    Article • Growth Hormone & IGF Research, April 2008, Elsevier

    Dr Alan David Rogol

  71. Idiopathic short stature: Management and growth hormone treatment

    Article • Growth Hormone & IGF Research, April 2008, Elsevier

    Dr Alan David Rogol

  72. Insulin Growth Factor-Based Dosing of Growth Hormone Therapy in Children: A Randomized, Controlled Study

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2007, Endocrine Society

    Dr Alan David Rogol

  73. Male pubertal development and the role of androgen therapy

    Article • Nature Clinical Practice Endocrinology &#38 Metabolism, April 2007, Springer Science + Business Media

    Dr Alan David Rogol

  74. Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2007, Endocrine Society

    Dr Alan David Rogol, Professor Gudmundur Johannsson

  75. Endocrinologie

    Article • Annales d Endocrinologie, February 2007, Elsevier

    Dr Alan David Rogol

  76. Puberty, Exercise and Bone Health

    Article • Hormone Research in Paediatrics, January 2007, Karger Publishers

    Dr Alan David Rogol

  77. Indicators of Biological Maturation and Secular Changes in Biological Maturation

    Article • Food and Nutrition Bulletin, December 2006, SAGE Publications

    Dr Alan David Rogol

  78. Persistent Hypercalcemia After Parathyroidectomy in an Adolescent and Effect of Treatment With Cinacalcet HCl

    Article • Clinical Chemistry, December 2006, Oxford University Press (OUP)

    Dr Alan David Rogol

  79. Bone age and onset of puberty in normal boys

    Article • Molecular and Cellular Endocrinology, July 2006, Elsevier

    Dr Alan David Rogol

  80. Update of Newborn Screening and Therapy for Congenital Hypothyroidism

    Article • PEDIATRICS, June 2006, American Academy of Pediatrics (AAP)

    Dr Alan David Rogol

  81. Pharmacokinetic Studies of Recombinant Human Insulin-Like Growth Factor I (rhIGF-I)/rhIGF-Binding Protein-3 Complex Administered to Patients with Growth Hormone Insensitivity Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2006, Endocrine Society

    Dr Alan David Rogol

  82. Increases in Overweight After Adenotonsillectomy in Overweight Children With Obstructive Sleep-Disordered Breathing Are Associated With Decreases in Motor Activity and Hyperactivity

    Article • PEDIATRICS, February 2006, American Academy of Pediatrics (AAP)

    Dr Alan David Rogol

  83. A Workshop on Pubertal Hormone Replacement Options in the United States

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2006, De Gruyter

    Dr Alan David Rogol

  84. Global Inequalities in Paediatric Endocrine Practice: Statement of Minimal Acceptable Care

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Dr Alan David Rogol

  85. Single-center experience with pediatric Cushing's disease

    Article • Journal of Neurosurgery Pediatrics, November 2005, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Alan David Rogol

  86. Pubertal alterations in growth and body composition: IX. Altered spontaneous secretion and metabolic clearance of growth hormone in overweight youth

    Article • Metabolism, October 2005, Elsevier

    Dr Alan David Rogol

  87. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose

    Article • Growth Hormone & IGF Research, August 2005, Elsevier

    Dr Alan David Rogol

  88. New facets of androgen replacement therapy during childhood and adolescence

    Article • Expert Opinion on Pharmacotherapy, July 2005, Informa Healthcare

    Dr Alan David Rogol

  89. Reduced Physical Activity And Increased Overweight Following Adenotonsillectomy In Children With Obstructive Sleep Apnea

    Article • Medicine & Science in Sports & Exercise, May 2005, Wolters Kluwer Health

    Dr Alan David Rogol

  90. Magnesium Deficiency Is Associated With Insulin Resistance in Obese Children

    Article • Diabetes Care, April 2005, American Diabetes Association

    Dr Alan David Rogol

  91. Childhood Obesity

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2005, Endocrine Society

    Dr Phyllis W Speiser, Dr Alan David Rogol

  92. Hormone Abuse in Adolescents and Adults

    Article • The Endocrinologist, March 2005, Wolters Kluwer Health

    Dr Alan David Rogol

  93. Anthropometric factors associated with age of menarche: An analysis of two cohorts across five decades

    Article • Journal of Adolescent Health, February 2005, Elsevier

    Dr Alan David Rogol

  94. Endocrine Control of Body Composition in Infancy, Childhood, and Puberty

    Article • Endocrine Reviews, February 2005, Endocrine Society

    Dr Alan David Rogol

  95. Diminished Insulin Resistance with Weight Loss in Severely Overweight Youth

    Article • Metabolic Syndrome and Related Disorders, September 2004, Mary Ann Liebert Inc

    Dr Alan David Rogol

  96. Klinefelter syndrome: Expanding the phenotype and identifying new research directions

    Article • Genetics in Medicine, November 2003, Nature

    wael salameh, Dr Alan David Rogol

  97. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

    Article • The Journal of Pediatrics, October 2003, Elsevier

    Dr Phyllis W Speiser, Dr Alan David Rogol

  98. Growth, body composition and hormonal axes in children and adolescents

    Article • Journal of Endocrinological Investigation, September 2003, Springer Science + Business Media

    Dr Alan David Rogol

  99. Delayed Onset of Pubertal Development in Children and Adolescents With Perinatally Acquired HIV Infection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2003, Wolters Kluwer Health

    Dr Alan David Rogol

  100. Relationship of Leptin to Bone Mineralization in Children and Adolescents

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2003, Endocrine Society

    Dr Alan David Rogol

  101. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?

    Article • Clinical Endocrinology, February 2003, Wiley

    Dr Alan David Rogol

  102. Growth at puberty

    Article • Journal of Adolescent Health, December 2002, Elsevier

    Dr Alan David Rogol

  103. Androgens and puberty

    Article • Molecular and Cellular Endocrinology, December 2002, Elsevier

    Dr Alan David Rogol

  104. XXY

    Article • Infants & Young Children, July 2002, Wolters Kluwer Health

    Dr Alan David Rogol

  105. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release

    Article • International Journal of Obesity, May 2002, Springer Science + Business Media

    Dr Alan David Rogol

  106. Consequences of sport training during puberty

    Article • Journal of Endocrinological Investigation, October 2001, Springer Science + Business Media

    Dr Alan David Rogol

  107. D-chiro-inositol (INS-1) enhances ovulatory rate in hyperandrogenemic, oligomenorrheic women with the polycystic ovary syndrome.

    Article • Fertility and Sterility, September 2001, Elsevier

    Dr Alan David Rogol

  108. Lipoid Congenital Adrenal Hyperplasia (CAH): Patient Report and a Mini-Review

    Article • Clinical Pediatrics, July 2001, SAGE Publications

    Dr Alan David Rogol

  109. Alterations in body composition and fat distribution in growth hormone—Deficient prepubertal children during growth hormone therapy

    Article • Metabolism, May 2001, Elsevier

    Dr Alan David Rogol

  110. Early menarche and adult height: Reprise of the hare and the tortoise?

    Article • The Journal of Pediatrics, May 2001, Elsevier

    Dr Alan David Rogol

  111. The Insulin-Like Growth Factor System in Kidney Diseases

    Article • January 2001, Karger Publishers

    Dr Alan David Rogol

  112. Alterations in growth and body composition during puberty. IV. Energy intake estimated by the Youth-Adolescent Food-Frequency Questionnaire: validation by the doubly labeled water method

    Article • American Journal of Clinical Nutrition, December 2000, Oxford University Press (OUP)

    Dr Alan David Rogol

  113. Pubertal alterations in growth and body composition. V. Energy expenditure, adiposity, and fat distribution

    Article • AJP Endocrinology and Metabolism, December 2000, American Physiological Society

    Dr Alan David Rogol

  114. Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase Deficiency

    Article • New England Journal of Medicine, November 2000, New England Journal of Medicine (NEJM/MMS)

    Dr Alan David Rogol

  115. Growth Hormone Stimulation Testing in Both Short and Normal Statured Children: Use of an Immunofunctional Assay

    Article • Pediatric Research, November 2000, Springer Science + Business Media

    Dr Alan David Rogol

  116. Growth and pubertal development in children and adolescents: effects of diet and physical activity

    Article • American Journal of Clinical Nutrition, August 2000, Oxford University Press (OUP)

    Dr Alan David Rogol

  117. Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys

    Article • AJP Endocrinology and Metabolism, August 2000, American Physiological Society

    Dr Alan David Rogol

  118. Sex steroid and growth hormone supplementation to enhance performance in adolescent athletes

    Article • Current Opinion in Pediatrics, August 2000, Wolters Kluwer Health

    Dr Alan David Rogol

  119. Gender and Sexual Maturation-Dependent Contrasts in the Neuroregulation of Growth Hormone Secretion in Prepubertal and Late Adolescent Males and Females--A General Clinical Research Center-Based Study

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2000, Endocrine Society

    Dr Alan David Rogol

  120. Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty

    Article • Journal of Tropical Pediatrics, April 2000, Oxford University Press (OUP)

    Dr Alan David Rogol

  121. Longitudinal assessment of hormonal and physical alterations during normal puberty in boys. VI. Modeling of growth velocity, mean growth hormone (GH mean), and serum testosterone (T) concentrations

    Article • American Journal of Human Biology, January 2000, Wiley

    Dr Alan David Rogol

  122. ROLE OF LEPTIN DURING CHILDHOOD GROWTH AND DEVELOPMENT

    Article • Endocrinology and Metabolism Clinics of North America, December 1999, Elsevier

    Dr Alan David Rogol

  123. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IFG-I) concentration in patients with beta thalassaemia and delayed growth

    Article • Journal of Tropical Pediatrics, December 1999, Oxford University Press (OUP)

    Dr Alan David Rogol

  124. Evidence Supporting an AdipoLeptin-Growth Hormone Axis in Obesity-Related Hyposomatotropism

    Article • The Endocrinologist, November 1999, Wolters Kluwer Health

    Dr Alan David Rogol

  125. Growth Hormone Deficiency in a Child with Sarcoidosis

    Article • Clinical Pediatrics, June 1999, SAGE Publications

    Dr Alan David Rogol

  126. Androgen replacement in children with constitutional delay of puberty: The case for aggressive therapy

    Article • Baillière s Clinical Endocrinology and Metabolism, October 1998, Elsevier

    Dr Alan David Rogol

  127. Discordant phenotypes and 45,X/46,X,idic(Y).

    Article • Journal of Medical Genetics, October 1998, BMJ

    Dr Alan David Rogol

  128. An immunofunctional GH assay: Use in children

    Article • Growth Hormone & IGF Research, August 1998, Elsevier

    Dr Alan David Rogol

  129. Repeated bouts of exercise alter the blood lactate-RPE relation

    Article • Medicine & Science in Sports & Exercise, July 1998, Wolters Kluwer Health

    Dr Alan David Rogol

  130. Discordant Puberty in Monozygotic Twin Sisters with Neurofibromatosis Type 1 (NFl)

    Article • Clinical Pediatrics, May 1998, SAGE Publications

    Dr Alan David Rogol

  131. Alterations in Growth and Body Composition During Puberty: III. Influence of Maturation, Gender, Body Composition, Fat Distribution, Aerobic Fitness, and Energy Expenditure on Nocturnal Growth Hormone Release

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1998, Endocrine Society

    Dr Alan David Rogol

  132. Human growth hormone response to repeated bouts of aerobic exercise

    Article • Journal of Applied Physiology, November 1997, American Physiological Society

    Dr Alan David Rogol

  133. Estrogen and Testosterone, But Not a Nonaromatizable Androgen, Direct Network Integration of the Hypothalamo-Somatotrope (Growth Hormone)-Insulin-Like Growth Factor I Axis in the Human: Evidence from Pubertal Pathophysiology and Sex-Steroid Hormone Rep...

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1997, Endocrine Society

    Dr Alan David Rogol

  134. Comparison of Pulsatile Luteinizing Hormone Secretion Between Prepubertal Children and Young Adults: Evidence for a Mass/Amplitude-Dependent Difference Without Gender or Day/Night Contrasts

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1997, Endocrine Society

    Dr Alan David Rogol

  135. Exercise and growth hormone: Does one affect the other?

    Article • The Journal of Pediatrics, July 1997, Elsevier

    Dr Alan David Rogol

  136. Partial growth-hormone insensitivity: The role of growth-hormone receptor mutations in idiopathic short stature

    Article • The Journal of Pediatrics, July 1997, Elsevier

    Dr Alan David Rogol

  137. A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. V. Rising Leptin Levels May Signal the Onset of Puberty

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1997, Endocrine Society

    Dr Alan David Rogol

  138. Maturation of the Regulation of Growth Hormone Secretion in Young Males with Hypogonadotropic Hypogonadism Pharmacologically Exposed to Progressive Increments in Serum Testosterone

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1997, Endocrine Society

    Dr Alan David Rogol

  139. Serum Lipid Levels and Steroidal Hormones in Women Runners With Irregular Menses

    Article • Canadian Journal of Applied Physiology, February 1997, Canadian Science Publishing

    Dr Alan David Rogol

  140. The Short-Term Infusion of Ovine Corticotropin-Releasing Hormone Does Not Alter Luteinizing Hormone Concentrations in Young Adult Men

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1997, Endocrine Society

    Dr Alan David Rogol

  141. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. III. The neuroendocrine growth hormone axis during late prepuberty

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1996, Endocrine Society

    Dr Alan David Rogol

  142. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1996, Endocrine Society

    Dr Alan David Rogol

  143. GROWTH HORMONES AND SEX STEROID INTERACTIONS AT PUBERTY

    Article • Endocrinology and Metabolism Clinics of North America, September 1996, Elsevier

    Dr Alan David Rogol

  144. Mode of pulsatile follicle-stimulating hormone secretion in gonadal hormone-sufficient and -deficient women--a clinical research center study

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1996, Endocrine Society

    Dr Alan David Rogol

  145. National Cooperative Growth Study substudy II: Do growth hormone levels from serial sampling add important diagnostic information?

    Article • The Journal of Pediatrics, May 1996, Elsevier

    Dr Alan David Rogol

  146. Sex Steroids, Growth Hormone, Insulin-Like Growth Factor-1: Neuroendocrine and Metabolic Regulation in Puberty

    Article • Hormone Research, January 1996, Karger Publishers

    Dr Alan David Rogol

  147. Radiological Case of the Month

    Article • Archives of Pediatrics and Adolescent Medicine, June 1995, American Medical Association (AMA)

    Dr Alan David Rogol

  148. Absent pituitary gland in two brothers with an oral-facial-digital syndrome resembling OFDS II and VI: A new type of OFDS?

    Article • American Journal of Medical Genetics, May 1995, Wiley

    Dr Alan David Rogol

  149. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1995, Endocrine Society

    Dr Alan David Rogol

  150. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis

    Article • Science, March 1995, American Association for the Advancement of Science

    Dr Alan David Rogol

  151. Growth Hormone Secretory Dynamics During Puberty

    Article • January 1995, Springer Science + Business Media

    Dr Alan David Rogol

  152. Regulatory Actions of Testosterone on Pulsatile Growth Hormone Secretion in the Human: Studies Using Deconvolution Analysis

    Article • January 1995, Springer Science + Business Media

    Dr Alan David Rogol

  153. Dexamethasone therapy for isosexual precocious pseudopuberty caused by generalized glucocorticoid resistance

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1994, Endocrine Society

    Dr Alan David Rogol

  154. Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans

    Article • Trends in Endocrinology and Metabolism, September 1994, Elsevier

    Dr Alan David Rogol

  155. Case 2

    Article • Archives of Pediatrics and Adolescent Medicine, July 1994, American Medical Association (AMA)

    Dr Alan David Rogol

  156. Growth at puberty: interaction of androgens and growth hormone

    Article • Medicine & Science in Sports & Exercise, June 1994, Wolters Kluwer Health

    Dr Alan David Rogol

  157. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1994, Endocrine Society

    Dr Alan David Rogol

  158. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1994, Endocrine Society

    Dr Alan David Rogol

  159. Androgen-Receptor Blockade Enhances Pulsatile Luteinizing Hormone Production in Late Pubertal Males: Evidence for a Hypothalamic Site of Physiologic Androgen Feedback Action

    Article • Pediatric Research, January 1994, Springer Science + Business Media

    Dr Alan David Rogol

  160. Growth and the Child with Diabetes Mellitus

    Article • Diabetes Care, December 1993, American Diabetes Association

    Dr Alan David Rogol

  161. Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1993, Endocrine Society

    Dr Alan David Rogol

  162. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum growth hormone-binding protein

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1993, Endocrine Society

    Dr Alan David Rogol

  163. Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1993, Endocrine Society

    Dr Alan David Rogol

  164. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1993, Endocrine Society

    Dr Alan David Rogol

  165. Alterations in the neuroendocrine control of growth hormone secretion in the uremic rat

    Article • Kidney International, May 1993, Elsevier

    Dr Alan David Rogol

  166. Altered Growth Hormone Secretory Dynamics in Prepubertal Males with Constitutional Delay of Growth

    Article • Pediatric Research, March 1993, Springer Science + Business Media

    Dr Alan David Rogol

  167. Long-Term Endurance Training Alters the Hypothalamic-Pituitary Axes for Gonadotropins and Growth Hormone

    Article • Endocrinology and Metabolism Clinics of North America, December 1992, Elsevier

    Dr Alan David Rogol

  168. Elevated Growth Hormone Secretory Rate in Premature Infants: Deconvolution Analysis of Pulsatile Growth Hormone Secretion in the Neonate

    Article • Pediatric Research, September 1992, Springer Science + Business Media

    Dr Alan David Rogol

  169. Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpuise LH concentrations in normal women during the early phase of the menstrual cycle

    Article • Journal of Endocrinological Investigation, July 1992, Springer Science + Business Media

    Dr Alan David Rogol

  170. The Effect of Training Intensity on Ratings of Perceived Exertion

    Article • International Journal of Sports Medicine, July 1992, Thieme Publishing Group

    Dr Alan David Rogol

  171. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence

    Article • Endocrine Reviews, May 1992, Endocrine Society

    Dr Alan David Rogol

  172. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1992, Endocrine Society

    Dr Alan David Rogol

  173. Exercise Training at and above the Lactate Threshold in Previously Untrained Women

    Article • International Journal of Sports Medicine, April 1992, Thieme Publishing Group

    Dr Alan David Rogol

  174. Durability of the reproductive axis in eumenorrheic women during 1 yr of endurance training

    Article • Journal of Applied Physiology, April 1992, American Physiological Society

    Dr Alan David Rogol

  175. Anabolic-Androgenic Steroids and the Adolescent

    Article • Pediatric Annals, March 1992, SLACK, Inc.

    Dr Alan David Rogol

  176. Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women

    Article • Endocrine Reviews, February 1992, Endocrine Society

    Dr Alan David Rogol

  177. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1992, Endocrine Society

    Dr Alan David Rogol

  178. Exogenous Androgen Does Not Alter Hypothalamic Proopiomelanocortin Gene Transcript Levels in the Sexually Immature Male Rat

    Article • Neuroendocrinology, January 1992, Karger Publishers

    Dr Alan David Rogol

  179. Primary amenorrhea in two postpubertal girls with underlying malignancy

    Article • Adolescent and Pediatric Gynecology, January 1992, Elsevier

    Dr Alan David Rogol

  180. Estrogenic Modulation of the Gonadotropin-Releasing Hormone-Stimulated Secretory Activity of the Gonadotrope and Lactotrope in Prepubertal Females with Turner's Syndrome*

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1991, Endocrine Society

    Dr Alan David Rogol

  181. Letters to the Editor

    Article • Journal of Tropical Pediatrics, December 1991, Oxford University Press (OUP)

    Dr Alan David Rogol

  182. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: Evidence for defective target organ responsiveness in the Mauriac syndrome

    Article • Metabolism, October 1991, Elsevier

    Dr Alan David Rogol

  183. Growth Hormone-Binding Protein Activity Is Inversely Related to 24-Hour Growth Hormone Release in Normal Boys*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1991, Endocrine Society

    Dr Alan David Rogol

  184. Augmented Hypothalamic Proopiomelanocortin Gene Expression with Pubertal Development in the Male Rat: Evidence for an Androgen Receptor-Independent Action*

    Article • Endocrinology, February 1991, Endocrine Society

    Dr Alan David Rogol

  185. Salpingitis in a sexually inactive adolescent with congenital virilizing adrenal hyperplasia

    Article • Adolescent and Pediatric Gynecology, January 1991, Elsevier

    Dr Alan David Rogol

  186. Reliability of Estimates of Pulsatile Characteristics of Luteinizing Hormone and Growth Hormone Release in Women*

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1990, Endocrine Society

    Dr Alan David Rogol

  187. Increased hGH Production Rate after Low-Dose Estrogen Therapy in Prepubertal Girls with Turner's Syndrome

    Article • Pediatric Research, December 1990, Springer Science + Business Media

    Dr Alan David Rogol

  188. Testosterone and Oxandrolone, a Nonaromatizable Androgen, Specifically Amplify the Mass and Rate of Growth Hormone (GH) Secreted per Burst without Altering GH Secretory Burst Duration or Frequency or the GH Half-Life*

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1990, Endocrine Society

    Dr Alan David Rogol

  189. Prediction of Lactate Threshold (LT) and Fixed Blood Lactate Concentrations (FBLC) from 3200-m Running Performance in Women*

    Article • International Journal of Sports Medicine, October 1990, Thieme Publishing Group

    Dr Alan David Rogol

  190. Physical Exercise and Menstrual Cycle Alterations

    Article • Sports Medicine, October 1990, Springer Science + Business Media

    Dr Alan David Rogol

  191. Clinical Utility of Cycle Exercise for the Physiologic Assessment of Growth Hormone Release in Children

    Article • Archives of Pediatrics and Adolescent Medicine, September 1990, American Medical Association (AMA)

    Dr Alan David Rogol

  192. Variations of Pulsatile Growth Hormone Release in Healthy Short Prepubertal Boys

    Article • Pediatric Research, July 1990, Springer Science + Business Media

    Dr Alan David Rogol

  193. Growth Hormone-Releasing Hormone and Growth Hormone-Releasing Peptide as Potential Therapeutic Modalities

    Article • Acta Paediatrica, April 1990, Wiley

    Dr Alan David Rogol

  194. Primary Cortisol Resistance Presenting as Isosexual Precocity*

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1990, Endocrine Society

    Dr Alan David Rogol

  195. Atenolol Enhances Nocturnal Growth Hormone (GH) Release in GH-Deficient Children during Long Term GH-Releasing Hormone Therapy*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1990, Endocrine Society

    Dr Alan David Rogol

  196. Somatostatin Inhibition of Growth Hormone Secretion by Somatotropes from Male, Female, and Androgen Receptor-Deficient Rats: Evidence for Differing Sensitivities*

    Article • Endocrinology, December 1989, Endocrine Society

    Dr Alan David Rogol

  197. Specific, Time-Dependent Actions of Low-Dose Ethinyl Estradiol Administration on the Episodic Release of Growth Hormone, Follicle-Stimulating Hormone, and Luteinizing Hormone in Prepubertal Girls with Turner's Syndrome *

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1989, Endocrine Society

    Dr Alan David Rogol

  198. Serum Cortisol Concentrations in Children with Protein-Energy Malnutrition

    Article • Annals of Saudi Medicine, November 1989, King Faisal Specialist Hospital and Research Centre

    Dr Alan David Rogol

  199. Alterations in the Pulsatile Properties of Circulating Growth Hormone Concentrations during Puberty in Boys*

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1989, Endocrine Society

    Dr Alan David Rogol

  200. Growth Hormone Secretion by Individual Somatotropes of the Testicular Feminized Rat*

    Article • Endocrinology, March 1989, Endocrine Society

    Dr Alan David Rogol

  201. Androgen-dependent somatotroph function in a hypogonadal adolescent male: Evidence for control of exogenous androgens on growth hormone release

    Article • Metabolism, March 1989, Elsevier

    Dr Alan David Rogol

  202. Percentages of Maximal Heart Rate, Heart Rate Reserve, and V̇O2peak for Determining Endurance Training Intensity in Sedentary Women*

    Article • International Journal of Sports Medicine, February 1989, Thieme Publishing Group

    Dr Alan David Rogol

  203. Prediction of Lactate Threshold and Fixed Blood Lactate Concentrations from 3200-m Time Trial Running Performance in Untrained Females*

    Article • International Journal of Sports Medicine, February 1989, Thieme Publishing Group

    Dr Alan David Rogol

  204. Treatment of the Young Child With Postoperative Central Diabetes Insipidus

    Article • Archives of Pediatrics and Adolescent Medicine, February 1989, American Medical Association (AMA)

    Dr Alan David Rogol

  205. Enhanced clearance of vancomycin by hemodialysis in a child

    Article • Pediatric Nephrology, January 1989, Springer Science + Business Media

    Dr Alan David Rogol

  206. Acute Androgen Receptor Blockade Increases Luteinizing Hormone Secretory Activity in Men*

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1988, Endocrine Society

    Dr Alan David Rogol

  207. A Persistent Pattern of Varying Pituitary Responsivity to Exogenous Growth Hormone (GH)-Releasing Hormone in GH-Deficient Children: Evidence Supporting Periodic Somatostatin Secretion*

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1988, Endocrine Society

    Dr Alan David Rogol

  208. Acceleration of Growth Rate in Growth Hormone-Deficient Children Treated with Human Growth Hormone-Releasing Hormone

    Article • Pediatric Research, August 1988, Springer Science + Business Media

    Dr Alan David Rogol

  209. Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators

    Article • Science, April 1988, American Association for the Advancement of Science

    Dr Alan David Rogol

  210. Atenolol Enhances Growth Hormone Release to Exogenous Growth Hormone-Releasing Hormone but Fails to Alter Spontaneous Nocturnal Growth Hormone Secretion in Boys with Constitutional Delay of Growth

    Article • Pediatric Research, April 1988, Springer Science + Business Media

    Dr Alan David Rogol

  211. Contemporary Aspects of Discrete Peak-Detection Algorithms. I. The Paradigm of the Luteinizing Hormone Pulse Signal in Men*

    Article • Endocrine Reviews, February 1988, Endocrine Society

    Dr Alan David Rogol

  212. Physiological Profiles of Episodic Progesterone Release During the Midluteal Phase of the Human Menstrual Cycle: Analysis of Circadian and Ultradian Rhythms, Discrete Pulse Properties, and Correlations With Simultaneous Luteinizing Hormone Release*

    Article • The Journal of Clinical Endocrinology & Metabolism, February 1988, Endocrine Society

    Dr Alan David Rogol

  213. Prediction of Lactate Threshold and Fixed Blood Lactate Concentrations from 3200-m Running Performance in Male Runners

    Article • International Journal of Sports Medicine, December 1987, Thieme Publishing Group

    Dr Alan David Rogol

  214. Physiological Attributes of Episodic Testosterone Secretion

    Article • Annals of the New York Academy of Sciences, December 1987, Wiley

    Dr Alan David Rogol

  215. Operating Characteristics of the Male Hypothalamo-Pituitary-Gonadal Axis: Pulsatile Release of Testosterone and Follicle-Stimulating Hormone and Their Temporal Coupling with Luteinizing Hormone*

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1987, Endocrine Society

    Dr Alan David Rogol

  216. Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas

    Article • Journal of Endocrinological Investigation, October 1987, Springer Science + Business Media

    Dr Alan David Rogol

  217. Modulating actions of estradiol on gonadotropin-releasing hormone—stimulated prolactin secretion in postmenopausal individuals

    Article • American Journal of Obstetrics and Gynecology, August 1987, Elsevier

    Dr Alan David Rogol

  218. Arginine-Induced Insulin and Growth Hormone Secretion in Children with Nutritional Rickets

    Article • Journal of Pediatric Gastroenterology and Nutrition, July 1987, Wolters Kluwer Health

    Dr Alan David Rogol

  219. Sustained Inhibitory Actions of a Potent Antagonist of Gonadotropin-Releasing Hormone in Postmenopausal Women*

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1987, Endocrine Society

    Dr Alan David Rogol

  220. Impact of intensive venous sampling on characterization of pulsatile GH release

    Article • AJP Endocrinology and Metabolism, April 1987, American Physiological Society

    Dr Alan David Rogol

  221. Selective β1-adrenergic receptor-blockade with atenolol enhances growth hormone releasing hormone and mediated growth hormone release in man

    Article • Metabolism, April 1987, Elsevier

    Dr Alan David Rogol

  222. Augmentation of Growth Hormone Secretion during Puberty: Evidence for a Pulse Amplitude-Modulated Phenomenon*

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1987, Endocrine Society

    Dr Alan David Rogol

  223. Actions of estradiol on discrete attributes of the luteinizing hormone pulse signal in man. Studies in postmenopausal women treated with pure estradiol.

    Article • Journal of Clinical Investigation, March 1987, American Society for Clinical Investigation

    Dr Alan David Rogol

  224. Effects of Sex and Age on the 24-Hour Profile of Growth Hormone Secretion in Man: Importance of Endogenous Estradiol Concentrations*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1987, Endocrine Society

    Dr Alan David Rogol

  225. Response of Anterior Pituitary Cells to Culture Media

    Article • Endocrine Research, January 1987, Taylor & Francis

    Dr Alan David Rogol

  226. Serum Insulin-Like Growth Factors I and II Concentrations and Growth Hormone and Insulin Responses to Arginine Infusion in Children with Protein-Energy Malnutrition before and after Nutritional Rehabilitation

    Article • Pediatric Research, November 1986, Springer Science + Business Media

    Dr Alan David Rogol

  227. Endocrine impact of pure estradiol replacement in postmenopausal women: Alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations

    Article • American Journal of Obstetrics and Gynecology, August 1986, Elsevier

    Dr Alan David Rogol

  228. Partial Insulin Resistance in the Mouse BC3H-1 Cell Line: Absent Hexose-Independent Actions of Insulin*

    Article • Endocrinology, July 1986, Endocrine Society

    Dr Alan David Rogol

  229. Appraising Endocrine Pulse Signals at Low Circulating Hormone Concentrations: Use of Regional Coefficients of Variation in the Experimental Series To Analyze Pulsatile Luteinizing Hormone Release

    Article • Pediatric Research, July 1986, Springer Science + Business Media

    Dr Alan David Rogol

  230. Role of Endogenous Opiates in Pubertal Maturation: Opposing Actions of Naltrexone in Prepubertal and Late Pubertal Boys*

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1986, Endocrine Society

    Dr Alan David Rogol

  231. Pituitary self-priming actions of gonadotropin-releasing hormone. Kinetics of estradiol's potentiating effects on gonadotropin-releasing hormone-facilitated luteinizing hormone and follicle-stimulating hormone release in healthy postmenopausal women.

    Article • Journal of Clinical Investigation, June 1986, American Society for Clinical Investigation

    Dr Alan David Rogol

  232. Physiological Properties of the Luteinizing Hormone Pulse Signal: Impact of Intensive and Extended Venous Sampling Paradigms on Its Characterization in Healthy Men and Women*

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1986, Endocrine Society

    Dr Alan David Rogol

  233. Failure to Detect the “Dawn Phenomenon” in Nondiabetic Subjects with Markedly Different Patterns of Nocturnal Growth Hormone Secretion*

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1986, Endocrine Society

    Dr Alan David Rogol

  234. Metabolic clearance of biologically active luteinizing hormone in man.

    Article • Journal of Clinical Investigation, April 1986, American Society for Clinical Investigation

    Dr Alan David Rogol

  235. The Effect of Androgens on the Pulsatile Release and the Twenty-Four-Hour Mean Concentration of Growth Hormone in Peripubertal Males*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1986, Endocrine Society

    Dr Alan David Rogol

  236. Carbamazkpine Toxicity: Comparison of Measurement of Drug Levels by HPLC and Emit and Model of Carbamazepine Kinetics

    Article • Journal of Toxicology Clinical Toxicology, January 1986, Taylor & Francis

    Dr Alan David Rogol

  237. Clinical Studies with GHRH in Man

    Article • Hormone Research, January 1986, Karger Publishers

    Dr Alan David Rogol

  238. Endogenous Opiates Participate in the Regulation of Pulsatile Luteinizing Hormone Release in an Unopposed Estrogen Milieu: Studies in Estrogen-Replaced, Gonadectomized Patients with Testicular Feminization*

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1985, Endocrine Society

    Dr Alan David Rogol

  239. Exercise-Induced Menstrual Disorders

    Article • New England Journal of Medicine, September 1985, New England Journal of Medicine (NEJM/MMS)

    Dr Alan David Rogol

  240. Altered Neuroendocrine Regulation of Gonadotropin Secretion in Women Distance Runners*

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1985, Endocrine Society

    Dr Alan David Rogol

  241. Pathophysiology of Male Hypogonadism Associated with Endogenous Hyperestrogenism

    Article • New England Journal of Medicine, May 1985, New England Journal of Medicine (NEJM/MMS)

    Dr Alan David Rogol

  242. Growth Hormone Releasing Hormone and Growth Hormone: Genetic Studies in Familial Growth Hormone Deficiency

    Article • Pediatric Research, May 1985, Springer Science + Business Media

    Dr Alan David Rogol

  243. Phorbol esters affect pituitary growth hormone (GH) and prolactin release: The interaction with GH releasing factor, somatostatin and bromocriptine

    Article • European Journal of Pharmacology, May 1985, Elsevier

    Dr Alan David Rogol

  244. 464 TESTOSTERONE (T) BUT NOT OXANDROLONE (OX) INCREASES SPONTANEOUS GROWTH HORMONE (GH) AND SOMATOMEDIN-C (SmC) CONCENTRATIONS IN BOYS WITH CONSTITUTIONAL DELAY OF GROWTH AND ADOLESCENCE (CDGA)

    Article • Pediatric Research, April 1985, Springer Science + Business Media

    Dr Alan David Rogol

  245. 468 AMINO ACID RESIDUES 93–96 OF THE HUMAN GROWTH HORMONE MOLECULE ARE IMPORTANT FOR POLYCLONAL ANTISERUM RECOGNITION

    Article • Pediatric Research, April 1985, Springer Science + Business Media

    Dr Alan David Rogol

  246. Minimizing false-positive errors in hormonal pulse detection

    Article • AJP Endocrinology and Metabolism, April 1985, American Physiological Society

    Dr Alan David Rogol

  247. Agents that increase cellular cyclic AMP or calcium stimulate prolactin release from the 235-1 pituitary cell line

    Article • European Journal of Pharmacology, March 1985, Elsevier

    Dr Alan David Rogol

  248. Human pancreatic tumor GH-releasing factor

    Article • Acta Neurochirurgica, March 1985, Springer Science + Business Media

    Dr Alan David Rogol

  249. Acceleration of Growth in Two Children Treated with Human Growth Hormone-Releasing Factor

    Article • New England Journal of Medicine, January 1985, New England Journal of Medicine (NEJM/MMS)

    Dr Alan David Rogol

  250. Divergent Influences of the Structurally Dissimilar Calcium Entry Blockers, Diltiazem and Verapamil, on Thyrotropin- and Gonadotropin-Releasing Hormone- Stimulated Anterior Pituitary Hormone Secretion in Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1985, Endocrine Society

    Dr Alan David Rogol

  251. Crossed Fused Ectopia with a Blind Left Ureter in a Young Woman with Turner’s Syndrome: Sonographic and Radiological Demonstration of a Previously Undescribed Variant

    Article • The Journal of Urology, December 1984, Wolters Kluwer Health

    Dr Alan David Rogol

  252. Modulation of the Pulsatile Release of Biologically Active Luteinizing Hormone by Endogenous Opiates

    Article • Annals of the New York Academy of Sciences, December 1984, Wiley

    Dr Alan David Rogol

  253. Sex Differences in the Cyclic Adenosine 3′:5′-Monophosphate and Growth Hormone Response to Growth Hormone-Releasing Factor In Vitro

    Article • Biology of Reproduction, December 1984, Oxford University Press (OUP)

    Dr Alan David Rogol

  254. Effects of Human Pancreatic Growth Hormone-Releasing Factor-40 on Serum Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Somatomedin-C Concentrations in Normal Women throughout the Menstrual Cycle*

    Article • The Journal of Clinical Endocrinology & Metabolism, November 1984, Endocrine Society

    Dr Alan David Rogol

  255. Mesulergine, a new dopamine agonist: Effects on anterior pituitary function and kinetics

    Article • Clinical Pharmacology & Therapeutics, November 1984, Springer Science + Business Media

    Dr Alan David Rogol

  256. Growth Hormone Release in Response to Human Pancreatic Tumor Growth Hormone-Releasing Hormone-40 in Children with Short Stature*

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1984, Endocrine Society

    Dr Alan David Rogol

  257. Anti-insulin-like (diabetogenic) peptides in pituitary extracts: Role of oxytocin

    Article • Archives of Biochemistry and Biophysics, October 1984, Elsevier

    Dr Alan David Rogol

  258. Oxytocin: Anti-insulin-like effects in isolated fat cells

    Article • Archives of Biochemistry and Biophysics, October 1984, Elsevier

    Dr Alan David Rogol

  259. Performance of LH pulse-detection algorithms at rapid rates of venous sampling in humans

    Article • AJP Endocrinology and Metabolism, October 1984, American Physiological Society

    Dr Alan David Rogol

  260. Intensified Rates of Venous Sampling Unmask the Presence of Spontaneous, High-Frequency Pulsations of Luteinizing Hormone in Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1984, Endocrine Society

    Dr Alan David Rogol

  261. Divergent Influences of Calcium Ions on Releasing Factor-Stimulated Anterior Pituitary Hormone Secretion in Normal Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1984, Endocrine Society

    Dr Alan David Rogol

  262. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.

    Article • Journal of Clinical Investigation, July 1984, American Society for Clinical Investigation

    Dr Alan David Rogol

  263. The Effect of Exogenous Growth Hormone on Insulin Requirements during Closed Loop Insulin Delivery in Insulin-Dependent Diabetes Mellitus

    Article • Hormone and Metabolic Research, June 1984, Thieme Publishing Group

    Dr Alan David Rogol

  264. Human Pancreatic Tumor Growth Hormone-Releasing Factor: Dose-Response Relationships in Normal Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1984, Endocrine Society

    Dr Alan David Rogol

  265. Follicle-Stimulating Hormone-Secreting Pituitary Tumor with Concomitant Elevation of Serum α-Subunit Levels*

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1984, Endocrine Society

    Dr Alan David Rogol

  266. Generalized Convulsions as the Presenting Sign of Amoxapine Intoxication

    Article • Clinical Pediatrics, April 1984, SAGE Publications

    Dr Alan David Rogol

  267. Reversible growth hormone deficiency and delayed puberty triggered by a stressful experience in a young adult

    Article • The American Journal of Medicine, April 1984, Elsevier

    Dr Alan David Rogol

  268. Human Pancreatic Tumor Growth Hormone (GH)-Releasing Factor and Cyclic Adenosine 3′,5′-Monophosphate Evoke GH Release from Anterior Pituitary Cells: The Effects of Pertussis Toxin, Cholera Toxin, Forskolin, and Cycloheximide*

    Article • Endocrinology, March 1984, Endocrine Society

    Dr Alan David Rogol

  269. Autoimmunity in congenital rubella syndrome

    Article • The Journal of Pediatrics, March 1984, Elsevier

    Dr Alan David Rogol

  270. Effect of Testosterone on Somatomedin-C Concentrations in Prepubertal Boys*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1984, Endocrine Society

    Dr Alan David Rogol

  271. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome

    Article • Virchows Archiv A Pathological Anatomy and Histopathology, January 1984, Springer Science + Business Media

    Dr Alan David Rogol

  272. Doα-Adrenergic Mechanisms Regulate Spontaneous or Opiate-Modulated Pulsatile Luteinizing Hormone Secretion in Man?*

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1983, Endocrine Society

    Dr Alan David Rogol

  273. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.

    Article • Journal of Clinical Investigation, December 1983, American Society for Clinical Investigation

    Dr Alan David Rogol

  274. Prolactin secretion by human chorion-decidua in vitro: Influences of mode of delivery and agents that modify prostaglandin synthesis

    Article • American Journal of Obstetrics and Gynecology, September 1983, Elsevier

    Dr Alan David Rogol

  275. Pertussis Toxin Blocks the Somatostatin-Induced Inhibition of Growth Hormone Release and Adenosine 3′,5′ -Monophosphate Accumulation*

    Article • Endocrinology, July 1983, Endocrine Society

    Dr Alan David Rogol

  276. Naloxone Attenuates Recovery from Insulin-Induced Hypoglycemia in Normal Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1983, Endocrine Society

    Dr Alan David Rogol

  277. Reply

    Article • The Journal of Pediatrics, July 1983, Elsevier

    Dr Alan David Rogol

  278. The syndrome of anosmia with hypogonadotropic hypogonadism: A genetic study of 18 new families and a review

    Article • American Journal of Medical Genetics, July 1983, Wiley

    Dr Alan David Rogol

  279. Preliminary data on the dexamethasone suppression test in children with major depressive disorder

    Article • American Journal of Psychiatry, May 1983, American Psychiatric Association

    Dr Alan David Rogol

  280. Severe metabolic complications in a cross-country runner with sickle cell trait

    Article • JAMA, February 1983, American Medical Association (AMA)

    Dr Alan David Rogol

  281. Luteinizing Hormone Secretion Is Enhanced by Pertussis Toxin, Cholera Toxin, and Forskolin

    Article • Neuroendocrinology, January 1983, Karger Publishers

    Dr Alan David Rogol

  282. Apomorphine response and subtyping of schizophrenia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 1983, Elsevier

    Dr Alan David Rogol

  283. HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MAN

    Article • The Lancet, January 1983, Elsevier

    Dr Alan David Rogol

  284. Somatotroph Hyperplasia

    Article • Journal of Clinical Investigation, November 1982, American Society for Clinical Investigation

    Dr Alan David Rogol

  285. Tolmetin sodium in the management of nephrogenic diabetes insipidus

    Article • The Journal of Pediatrics, November 1982, Elsevier

    Dr Alan David Rogol

  286. Prolactin binding sites on human chorion-decidua tissue

    Article • American Journal of Obstetrics and Gynecology, October 1982, Elsevier

    Dr Alan David Rogol

  287. Syndrome of anosmia with hypogonadotropic hypogonadism (kallmann syndrome)

    Article • The American Journal of Medicine, October 1982, Elsevier

    Dr Alan David Rogol

  288. SELECTIVE GROWTH HORMONE AND CYCLIC AMP STIMULATING ACTIVITY IS PRESENT IN A HUMAN PANCREATIC ISLET CELL TUMOR

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1982, Endocrine Society

    Dr Alan David Rogol

  289. Naloxone in chronic schizophrenic patients: Neuroendocrine and behavioral effects

    Article • Psychiatry Research, August 1982, Elsevier

    Dr Alan David Rogol

  290. Insulin binding to the HL-60 human promyelocytic cell line

    Article • Molecular and Cellular Endocrinology, January 1982, Elsevier

    Dr Alan David Rogol

  291. Reproductive system function in women cross-country runners

    Article • Medicine & Science in Sports & Exercise, January 1982, Wolters Kluwer Health

    Dr Alan David Rogol

  292. Pergolide Mesylate: Its Effects on Circulating Anterior Pituitary Hormones in Man*

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1981, Endocrine Society

    Dr Alan David Rogol

  293. Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1981, Endocrine Society

    Dr Alan David Rogol

  294. Effect of acetate on glucose utilization by isolated rat thymocytes

    Article • Archives of Biochemistry and Biophysics, July 1981, Elsevier

    Dr Alan David Rogol

  295. Dopaminergic Mechanisms and Luteinizing Hormone (LH) Secretion. II. Differential Effects of Dopamine and Bromocriptine on LH Release in Normal Women*

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1981, Endocrine Society

    Dr Alan David Rogol

  296. Unusual heterogeneity of circulating prolactin in an acromegalic

    Article • Journal of Endocrinological Investigation, April 1981, Springer Science + Business Media

    Dr Alan David Rogol

  297. Effect of Ammonia on Glucose Oxidation by Isolated Rat Adipocytes

    Article • Hormone and Metabolic Research, March 1981, Thieme Publishing Group

    Dr Alan David Rogol

  298. Prolactin response to beta-endorphin in man

    Article • Life Sciences, November 1980, Elsevier

    Dr Alan David Rogol

  299. Rapid Regression of Pituitary Prolactinomas during Bromocriptine Treatment*

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1980, Endocrine Society

    Dr Alan David Rogol

  300. HLA-Compatible Paternity in Two “Fertile Eunuchs” with Congenital Hypogonadotropic Hypogonadism and Anosmia (the Kallmann Syndrome)

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1980, Endocrine Society

    Dr Alan David Rogol

  301. Failure of Cortisol Blockade to Inhibit Early Morning Increases in Basal Insulin Requirements in Fasting Insulin-dependent Diabetics

    Article • Diabetes, August 1980, American Diabetes Association

    Dr Alan David Rogol

  302. A Broad Spectrum of Prolactin Suppression by Bromocriptine in Hyperprolactinemic Women: A Study of Serum Prolactin and Bromocriptine Levels after Acute and Chronic Administration ofBromocriptine*

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1980, Endocrine Society

    Dr Alan David Rogol

  303. Dopaminergic Mechanisms and Luteinizing Hormone Secretion. I. Acute Administration of the Dopamine Agonist Bromocriptine Does Not Inhibit Luteinizing Hormone Release in Hyperprolactinemic Women*

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1980, Endocrine Society

    Dr Alan David Rogol

  304. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man

    Article • Science, October 1979, American Association for the Advancement of Science

    Dr Alan David Rogol

  305. Indirect Immunofluorescent Localization of Prolactin to the Cytoplasm of Decidua and Trophoblast Cells in Human Placental Membranes at Term

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1979, Endocrine Society

    Dr Alan David Rogol

  306. Prolactin and pituitary tumors

    Article • The American Journal of Medicine, April 1979, Elsevier

    Dr Alan David Rogol

  307. Congenital Anosmia: Detection Thresholds for Seven Odorant Classes in Hypogonadal and Eugonadal Patients

    Article • Annals of Otology Rhinology & Laryngology, March 1979, SAGE Publications

    Dr Alan David Rogol

  308. Thyroid-Stimulating Hormone and Prolactin Responses to Thyrotropin-Releasing Hormone during Infusion of Epinephrine and Propranolol in Man

    Article • Neuroendocrinology, January 1979, Karger Publishers

    Dr Alan David Rogol

  309. Effect of prolactin on dopamine synthesis in medial basal hypothalamus: Evidence for a short loop feedback

    Article • Brain Research, January 1979, Elsevier

    Dr Alan David Rogol

  310. The Relationship of the Bovine Pituitary "Diabetogenic Peptide" to Prolactin

    Article • Hormone and Metabolic Research, November 1978, Thieme Publishing Group

    Dr Alan David Rogol

  311. Serum Prolactin Concentration in a Prepubertal Boy With Gynecomastia

    Article • Archives of Pediatrics and Adolescent Medicine, April 1978, American Medical Association (AMA)

    Dr Alan David Rogol

  312. PROPRANOLOL AND PROLACTIN

    Article • The Lancet, December 1977, Elsevier

    Dr Alan David Rogol

  313. Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: Relationship to dermatomyositis-like syndrome

    Article • The Journal of Pediatrics, March 1977, Elsevier

    Dr Alan David Rogol

  314. Characterization of Growth Hormone and Prolactin Produced by Human Pituitary in Culture

    Article • Endocrinology, February 1977, Endocrine Society

    Dr Alan David Rogol

  315. EFFECT OF CYPROHEPTADINE ON TRH-STIMULATED PROLACTIN AND TSH RELEASE IN MAN1 2 3

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1977, Endocrine Society

    Dr Alan David Rogol

  316. Congenital hypothyroidism in a young man with growth hormone, thyrotropin, and prolactin deficiencies

    Article • The Journal of Pediatrics, June 1976, Elsevier

    Dr Alan David Rogol

  317. Radioiodinated Human Pituitary and Amniotic Fluid Prolactins with Preserved Molecular Integrity

    Article • Endocrinology, August 1975, Endocrine Society

    Dr Alan David Rogol

  318. Response to LH-RH and Clomiphene Citrate in Two Women with the Prader-Labhart-Willi Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1975, Endocrine Society

    Dr Alan David Rogol

  319. Charge Properties of Human Pituitapy and Amniotic Fluid Prolactins

    Article • Endocrine Research Communications, January 1975, Taylor & Francis

    Dr Alan David Rogol

  320. Alteration of Human and Bovine Prolactins by a Chloramine T Radioiodination: Comparison with Lactoperoxidase-Iodinated Prolactins

    Article • The Journal of Clinical Endocrinology & Metabolism, August 1974, Endocrine Society

    Dr Alan David Rogol

  321. PROLACTIN OF APPARENT LARGE MOLECULAR SIZE: THE MAJOR IMMUNOACTIVE PROLACTIN COMPONENT IN PLASMA OF A PATIENT WITH A PITUITARY TUMOR1

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1974, Endocrine Society

    Dr Alan David Rogol

  322. HETEROGENEITY OF RESPONSE TO LH-RH IN PATIENTS WITH THE SYNDROME OF CONGENITAL ANOSMIA AND HYPOGONADISM

    Article • Pediatric Research, April 1974, Springer Science + Business Media

    Dr Alan David Rogol